Patents for A61P 35 - Antineoplastic agents (221,099) |
---|
11/02/1989 | EP0339596A2 Antibiotics TAN-1057 |
11/02/1989 | EP0339193A1 Peptide ligands for bombesin receptors |
11/02/1989 | DE3912867A1 4-desmethoxy-4'-desoxy-4'-jodoanthracyclinglycoside und verfahren zu deren herstellung 4-demethoxy-4'-deoxy-4'-jodoanthracyclinglycoside and processes for their preparation |
11/01/1989 | CN1036763A Condensed ouinoline system compound, condensed acridine system compound, process for preparing the same, and carcinostalic composition containing the same |
10/31/1989 | US4877883 Substituted pyrazoles |
10/31/1989 | US4877870 Process for producing 10-hydroxyanthracyclines |
10/31/1989 | US4877803 Bis-dioxopiperazine derivatives and pharmaceutical compositions containing the same |
10/31/1989 | US4877777 Immunobiological response in combination with anticancer drugs |
10/31/1989 | US4877776 K-252 compounds |
10/31/1989 | US4877739 Antiammonia azotobacter and the use thereof |
10/31/1989 | US4877610 Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms |
10/25/1989 | EP0338895A1 Heteroarotinoid derivatives, their processes of preparation and pharmaceutical compositions containing them |
10/25/1989 | EP0338767A2 Novel recombinant and chimeric antibodies directed against a human adenocarcinoma antigen |
10/25/1989 | EP0338087A1 Fused pyrazole compounds, process for their preparation, and their medicinal use |
10/25/1989 | EP0227826B1 Novel vitamin d analogues |
10/25/1989 | CN1036579A Novel acetylenic, cyano and allenic aristeromycin/adenosine derivatives |
10/25/1989 | CN1036578A Novel fluorophosphonate nucleotide derivatives |
10/25/1989 | CN1036567A Fused pyrimidines, their production and use |
10/24/1989 | US4876381 Naphthalene derivatives possessing a retinoid-type action, processes for their preparation, and medicinal and cosmetic compositions containing these derivatives |
10/24/1989 | US4876349 Antitumor agents |
10/24/1989 | US4876045 Process for the preparation of methylene derivatives of androsta-1,4-diene-3,17-dione |
10/19/1989 | WO1989009831A1 Lak cell cytotoxin |
10/19/1989 | WO1989009792A1 Method for potentiating and inhibiting insulin-like growth factor activity |
10/19/1989 | WO1989009623A1 Preparation for transporting radionuclides in a living organism |
10/19/1989 | WO1989009622A1 Il-2 receptor-specific chimeric antibodies |
10/19/1989 | WO1989009606A1 Pharmaceutical for treating tumors in humans and method for making it |
10/19/1989 | DE3910667A1 Peptide derivatives |
10/19/1989 | DE3910323A1 Biologically active proteins |
10/18/1989 | EP0337929A1 N-substituted imidazoles, process for their preparation and their pharmaceutical application |
10/18/1989 | EP0337928A1 N-substituted imidazoles, process for their preparation and their pharmaceutical application |
10/18/1989 | EP0337885A1 Trienic derivatives with chromenic structure, their processes of preparation and pharmaceutical compositions containing them |
10/18/1989 | EP0337689A1 Tetralin esters of phenols or benzoic acids having retinoid like activity |
10/18/1989 | EP0337601A1 Porphyrins and medicaments for cancer treatment |
10/18/1989 | EP0337430A2 Antitumor antibiotic kedarcidin |
10/18/1989 | EP0337413A2 Naphthopyran derivatives and use thereof |
10/18/1989 | EP0337176A2 Novel benzoic acid derivatives and process for preparing the same |
10/18/1989 | EP0336958A1 Product containing as active principles: a) a peptide having an activity of the type of that of human gamma interferon, b) hydroxyurea |
10/17/1989 | US4874898 Antiandrogens |
10/17/1989 | US4874863 Bisnaphthalimides |
10/17/1989 | US4874851 Antitumor agents |
10/17/1989 | US4874850 Pharmaceutical preparations |
10/17/1989 | US4874780 Anticancer compounds |
10/17/1989 | US4874779 Mitomycin phosphate derivatives |
10/17/1989 | US4874747 Polycyclic heterocyclic compounds, a process for their preparation and their use in human and veterinary medicine |
10/11/1989 | EP0336879A1 Meso-tetraphenylporphyrin complex compounds,process for their preparation and pharmaceuticals containing them |
10/11/1989 | EP0336841A1 Process for the preparation of baccatin III derivatives and of desacetyl-10 baccatin III |
10/11/1989 | EP0336840A1 Process for the preparation of taxol |
10/11/1989 | EP0336405A2 Anti-human cancer protein complexes, their production and use |
10/11/1989 | EP0336379A2 Antibody heteroconjugates for use in regulation of lymphocyte activity |
10/11/1989 | EP0336356A2 Derivatives of tryptophan as CCK antagonists |
10/11/1989 | EP0336349A2 Sakyomicin E and its derivatives. Process for its preparation and its applications |
10/11/1989 | EP0336345A2 (2S)-(5-Amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7-yl)-carbamic acid, ethyl ester |
10/11/1989 | EP0336142A2 Novel antagonists of platelet activating factor |
10/11/1989 | EP0335966A1 Vasoconstrictive substances in combination with cytotoxic agents |
10/11/1989 | EP0335900A1 Human interleukin-4 muteins |
10/11/1989 | CN1036207A Novel aspartate transcarbamylase inhibitors |
10/11/1989 | CN1036135A Growth inhibiting agent and use thereof |
10/10/1989 | US4873233 17-Substituted androsta-1,4-dien-3-one derivatives |
10/05/1989 | WO1989009271A1 Recombinant retroviruses |
10/05/1989 | WO1989009232A1 Neuropeptide antagonists |
10/05/1989 | WO1989009218A1 Platinum(ii) complexes, their preparation and use as anti-tumour agents |
10/05/1989 | WO1989009205A1 Methods for depletion of glutathione |
10/05/1989 | WO1989009062A1 Combination therapy of il-2 and dtic for the treatment of melanoma |
10/04/1989 | EP0335832A2 Aryl hydrazones |
10/04/1989 | EP0335770A2 Novel fluorophosphonate nucleotide derivatives |
10/04/1989 | EP0335550A1 Biologically active material characterised by catabolic activity generally associated with cachexia-inducing tumours, preparations, production and uses thereof |
10/04/1989 | EP0335539A2 Porphyrin derivatives |
10/04/1989 | EP0335446A2 Agents for treating neoplasms |
10/04/1989 | EP0335408A2 Substituted benzene derivatives, processes for their production and antitumour compositions containing them |
10/03/1989 | US4871870 Immunomodulators and method of making same |
10/03/1989 | US4871746 N-[N-(tetrahydropyrido[2,3-D]pyrimidinylmethyl)-aminomethylbenzoyl]glutamic acid derivatives as neoplastic growth inhibitors |
10/03/1989 | US4871743 Antitumor agents |
10/03/1989 | US4871720 Aromatically substituted azacycloalkyl-alkanediphosphonic acids useful for the treatment of illnesses that can be attributed to calcium metabolism disorders |
10/03/1989 | US4871717 Peptides |
10/03/1989 | CA1262097A1 In-vial deposition of 7-(dimethylaminomethylene) amino-9a-methoxymitosane |
09/27/1989 | EP0334576A2 Intraperitoneal treatment by chemotherapeutic agent and non-steroidal antiinflammatory drug |
09/27/1989 | EP0334425A1 Novel delta4 - androstene derivatives |
09/27/1989 | EP0334361A2 Novel acetylenic, cyano and allenic aristeromycin/adenosine derivatives |
09/27/1989 | EP0334301A1 Recombinant retroviruses |
09/27/1989 | EP0334300A1 The use of monoclonal antibodies and conjugates thereof as signals to direct sensitized effector cells to tumor sites |
09/27/1989 | EP0334083A1 Ifosfamide-mesna-lyophilized composition and process to prepare it |
09/26/1989 | US4870174 Imidozopyrionidines and their use in pharmaceutical preparations |
09/26/1989 | US4870172 Bisucaberin |
09/26/1989 | US4870070 Water soluble platinum complexes of novel malonate derivatives |
09/26/1989 | US4870062 Reduced nephrotoxicity |
09/26/1989 | US4869903 Human innumedeficiency virus; single-chain ribosome inactivating protein |
09/26/1989 | CA1262016A1 Anticancer agent |
09/26/1989 | CA1261864A1 Liposoluble platinum (ii) complex and preparation thereof |
09/26/1989 | CA1261863A1 Stable soluble 1,2-diaminocyclohexane platinum complexes |
09/26/1989 | CA1261833A1 7-hydroxyguanine compounds, process for preparing said compounds, and anti-tumor agent containing the same |
09/26/1989 | CA1260935A1 6-purinyl n-(2-chlorethyl) carbamate and thiocarbamate and a process for their preparation |
09/26/1989 | CA1260462A1 Ellipticine derivative and production process thereof |
09/21/1989 | WO1989008845A1 Antibodies, process for producing them, oligosaccharide haptens and clones for the production of the antibodies, and use of the antibodies for diagnosis and therapy of tumours |
09/21/1989 | WO1989008711A1 Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates |
09/21/1989 | WO1989008709A1 Biologically active material characterised by catabolic activity generally associated with cachexia-inducing tumours, preparations, production and uses thereof |
09/21/1989 | WO1989008666A1 Heparin-binding proteins, dna cuding for them, processes for producing them as well as therapeutic preparations containing them |
09/21/1989 | WO1989008647A1 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents |
09/21/1989 | WO1989008453A1 New, water soluble, antineoplastic derivatives of taxol |
09/21/1989 | DE3807594A1 Antikoerper, verfahren zu ihrer herstellung, oligosaccharid-haptene und klone zur erzeugung der antikoerper sowie verwendung der antikoerper zur diagnose und therapie von tumoren Antibodies, methods for their manufacture, oligosaccharide haptens and clones for production of antibodies and use of antibodies for diagnosis and therapy of tumors |
09/20/1989 | EP0333351A2 Platinum coordination compounds |